Timely & critical insights across the spectrum of pharma & biotech

HomeCategory

Biosimilar - PharmForward

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/09/FDA-ranibi-640x480.jpg

Biosimilar R & D, Regulatory & Policy

Samsung Bioepis receives FDA approval for first Ranibizumab (Lucentis®) Biosimilar

September 21, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/Semglee-First-Interchangeable-Biosimilar-640x480.jpg

Biosimilar R & D, Regulatory & Policy

Semglee becomes first biosimilar to gain interchangeability designation –A critical milestone

July 29, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/Intas-DongA-Meiji-640x480.jpg

Biosimilar Deals

Intas Acquires Global Rights for Stelara® Biosimilar

July 23, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/06/Teva-Bioeq-640x480.jpg

Biosimilar Deals

Teva partners with Bioeq to commercialize Lucentis® Biosimilar

June 29, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/04/Amneal-Completes-Acquisition-of-Kashiv-Specialty-Pharmaceuticals-640x480.jpg

Biosimilar Generics

Amneal acquires Kashiv Specialty Pharmaceuticals

April 26, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/03/US-Senate-passes-Bill-on-improving-educational-resources-for-biosimilars-640x480.jpg

Biosimilar R & D, Regulatory & Policy

US Senate passes Bill on improving educational resources for biosimilars

March 14, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/03/AZ-Junshi--640x480.jpg

Biosimilar Patented Drugs & Vaccines

Astra Zeneca and Junshi Biosceinces partner to commercialize Toripalimab

March 5, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/02/Enzene-Biosciences-receives-Marketing-Authorization-for-Teriparatide-640x480.jpg

Biosimilar R & D, Regulatory & Policy

Enzene Biosciences receives Marketing Authorization for Teriparatide

February 15, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/01/New-law-to-improve-USFDA-Purple-Book-transparency--640x480.jpg

Biosimilar R & D, Regulatory & Policy

New law to improve USFDA Purple Book transparency

January 22, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/12/Eli-Lilly-and-United-Health-Group-partner-for-COVID-19-study--640x480.jpg

Biosimilar COVID-19

Eli Lilly and United Health Group partner for COVID-19 study

December 10, 20200